Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NTRA vs GSK✓SelectedUSD · GSKNTRA vs GSK performance historyLatest closeAs of-5.70%11/20
Stock and ETF performance explorer

NTRA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,418.9%
GSK return
+97.2%
Excess return
+1,321.7%
Maximum drawdown
-77.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.7%-0.1%-5.6%-5.6%
7D-14.3%-5.3%-9.0%-12.5%
30D-33.9%-3.7%-30.2%-33.0%
3M-15.8%-7.3%-8.6%-13.6%
6M+33.4%-4.2%+37.7%+34.6%
YTD+19.3%+0.9%+18.5%+16.9%
1Y+21.2%+7.3%+13.9%+15.6%
3Y+399.0%+52.7%+346.3%+287.7%
5Y+165.0%+40.1%+124.9%+107.5%
10Y+2,182.1%+98.7%+2,083.4%+1,369.3%
All+1,418.9%+97.2%+1,321.7%+910.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling